WHO ICTRP trial

Analysis of the immune status in the whole blood of cancer patients

DRKS00032078 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00032078
Public title Analysis of the immune status in the whole blood of cancer patients
Scientific title Analysis of the immune status in the whole blood of cancer patients
Primary sponsor Uniklinik RWTH Aachen Allg.-, Viszeral- & Transplantationschirurgie
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions Tumors of the liver, bile ducts, intestines, pancreas
Interventions Group 1: In patients with tumors of the liver, bile ducts, intestine or pancreas, 1.2 ml of blood is collected before and after chemotherapy or surgery. The blood is treated in vitro with lipopolysaccharide (LPS) or phytohaemagglutinin…
Registration date Jun 15, 2023
Target size 400
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations